Does hipec improve outcomes in gastric cancer patients treated with perioperative chemotherapy and radical surgery? A propensity-score matched analysis.
Thiago Pereira DinizWilson Luiz da Costa-JúniorVictor Hugo Fonseca de JesusHéber S C RibeiroAlessandro L DinizAndré Luís de GodoyIgor Correia de FariasSilvio Mello TorresTiago C FelisminoFelipe Jose Fernandez CoimbraPublished in: Journal of surgical oncology (2020)
Treatment with HIPEC in patients who received perioperative chemotherapy and a D2-resection did not improve survival outcomes. Both ypT and ypN stages remained as the most important survival predictors in this cohort.